Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
300705.SZ
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
+12%
0.19
vs 0.17
Q1.23
+32%
0.22
vs 0.17
Q2.23
+52%
0.35
vs 0.23
Q3.23
+36%
0.33
vs 0.24
Q4.23
N/A
0.17
vs NA
Q1.24
+62%
0.36
vs 0.22
Q2.24
-7%
0.33
vs 0.35
Q3.24
+4%
0.34
vs 0.33
Q4.24
-25%
0.13
vs 0.17
Q1.25
-31%
0.25
vs 0.36
Sales Growth
YoY
Current
Estimates
Q1.23
+12%
501.9M vs 449.1M
Q2.23
+23%
715.8M vs 581.9M
Q3.23
+19%
675.2M vs 568.2M
Q4.23
NA
790M vs NA
Q1.24
+16%
584M vs 501.9M
Q2.24
+7%
766.4M vs 715.8M
Q3.24
+15%
779.7M vs 675.2M
Q4.24
-1%
784.8M vs 790M
Q1.25
+19%
696M vs 584M
Q2.25
-2%
748.1M vs 766.4M
Return on Equity
QoQ
Q2.23
+7%
0.07
vs 0.05
Q3.23
+6%
0.06
vs 0.07
Q4.23
+3%
0.03
vs 0.06
Q1.24
+6%
0.06
vs 0.03
Q2.24
+7%
0.07
vs 0.06
Q3.24
+7%
0.07
vs 0.07
Q4.24
+2%
0.02
vs 0.07
Q1.25
+5%
0.05
vs 0.02
Institutionnal Ownership
Relative Strength
300705.SZ
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Hunan Jiudian Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company offers antiallergic, anti-infective, and anti-inflammatory drugs; analgosies and gynecological medication products; digestive system products; chemical and Chinese patent medicines; medical instruments; APIs; and other products. It also provides outsourcing services for tablets, capsules, granules, oral solutions, syrups, etc. Hunan Jiudian Pharmaceutical Co., Ltd. is based in Changsha, China.
SHZ
0.01Â ( 0.06%)
Relative Strenght
Volume Buzz
16%
Earning Acce
No
Dist 52w H.
44%Forecast
455%2026-Revenue
424%2026-EPS
377%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
Quote Panel
Key Metrics
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 300705.SZ compares to sector?